NIT
AGIO icon

NumerixS Investment Technologies’s Agios Pharmaceuticals AGIO Stock Holding History

NumerixS Investment Technologies’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,299
Closed -$176K – 26
2020
Q2 		$176K Buy
+3,299
New +$153K 0.05% 419
2019
Q4 		– Sell
-100
Closed -$3K – 1028
2019
Q3 		$3K Sell
100
-600
-86% -$24.8K ﹤0.01% 977
2019
Q2 		$35K Buy
+700
New +$37.4K 0.01% 835
2019
Q1 		– Sell
-1,075
Closed -$49K – 1112
2018
Q4 		$49K Sell
1,075
-1,625
-60% -$100K 0.02% 772
2018
Q3 		$205K Buy
2,700
+1,600
+145% +$129K 0.04% 577
2018
Q2 		$91K Buy
+1,100
New +$95.9K 0.02% 779
2017
Q1 		– Sell
-2,200
Closed -$92K – 1144
2016
Q4 		$92K Sell
2,200
-3,341
-60% -$175K 0.01% 874
2016
Q3 		$293K Buy
+5,541
New +$241K 0.04% 555
2015
Q3 		– Sell
-11,800
Closed -$1.31M – 629
2015
Q2 		$1.31M Buy
+11,800
New +$1.27M 0.18% 147

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NumerixS Investment Technologies's AGIO Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Agios Pharmaceuticals (AGIO) in Q3 2020, closing a stake of 3,299 shares — an estimated $176K sold.

NumerixS Investment Technologies first reported a position in AGIO in Q2 2015 and held it in 9 quarters. The position peaked at $1.31M in Q2 2015. 214 funds tracked by Wall St. Rank hold AGIO as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining Agios Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 3,299 Agios Pharmaceuticals shares in Q3 2020, an estimated $176K.
  • NumerixS Investment Technologies first reported a position in Agios Pharmaceuticals in Q2 2015 and held it in 9 quarters.
  • NumerixS Investment Technologies's Agios Pharmaceuticals position peaked at $1.31M in Q2 2015.
  • 214 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.